跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jun 2, 2021
Approval ID
761dc842a44e4b03
Company
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
Type
Standard
Approval Details
Approval Id
761dc842a44e4b03
Drug Cima Aemps Name
ONTOZRY 12,5 mg COMPRIMIDOS + ONTOZRY 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
1211530001
Holder Company Name
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
Marketing Company Name
Angelini Pharma Espana S.L.
Authorization Date
2021-06-02
Dosage Form
COMPRIMIDO
Dose
12,5 mg + 25 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Angelini Pharma Italia Aziende Chimiche Riunite Angelini Francesc O A.C.R.A.F. S.P.A. Enunciabile An
Active Ingredients
CENOBAMATO
25 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jun 2, 2021
Approval ID
761dc842a44e4b03
Type
Standard
Back to CIMA-AEMPS Approvals